WHO ICTRP trial
Observational Study: Glycemic Control & CV Outcomes Among Patients With T2DM…
NCT04006379 · NIH Clinical Trials · Not recruiting
Key facts
| Trial ID | NCT04006379 |
|---|---|
| Public title | Observational Study: Glycemic Control & CV Outcomes Among Patients With T2DM Newly Initiating GLP1-RAs vs Basal Insulin |
| Scientific title | An Observational Study of Glycemic Control and Cardiovascular Outcomes Among Patients With Type 2 Diabetes Newly Initiating GLP1 Receptor Agonists Versus Basal Insulin in Routine Care Settings. |
| Primary sponsor | Brigham and Women's Hospital |
| Registry | NIH Clinical Trials |
| Recruitment status | Not recruiting |
| Study type | Observational |
| Countries | United States |
| Conditions | Diabetes Mellitus, Type 2 |
| Interventions | Drug: GLP-1 receptor agonist;Drug: Basal insulin |
| Registration date | Jan 7, 2019 |
| Target size | 20000 |
| Secondary IDs | GLP1vsBasalInsulin |
| Registry page | clinicaltrials.gov |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: